Pharmacists in Molalla, OR Accepting Medicare
11 Pharmacists found. Showing 1 - 11
 Ms. Esther Catts Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1525 W Main St, Molalla, OR 97038 Phone: 503-829-4855 Fax: 503-829-3486 |
 Mr. Ronald P Dulwick, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 103 Robbins St, Molalla, OR 97038 Phone: 503-829-9111 Fax: 360-213-2238 |
Brianna Christine Sattler, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 103 Robbins St, Molalla, OR 97038 Phone: 503-829-9111 |
Tori L Dulwick, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 103 Robbins St, Molalla, OR 97038 Phone: 503-829-9111 Fax: 360-213-2238 |
David Allan Schulberg, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 514 W Main St, Molalla, OR 97038 Phone: 503-829-4555 Fax: 503-829-4494 |
Mr. Brent A Jefferies, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 103 Robbins St, Molalla, OR 97038 Phone: 503-829-9111 Fax: 360-213-2238 |
Lacee L Muffett, RPH Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 103 Robbins St, Molalla, OR 97038 Phone: 503-829-9111 Fax: 360-213-2238 |
Mrs. Katrina Lawrence, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1525 W Main St, Molalla, OR 97038 Phone: 503-829-4855 Fax: 503-829-3486 |
Barbara J Seidel, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 514 W Main St, Molalla, OR 97038 Phone: 503-829-4555 |
Mr. John H Brunscheon, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1525 W Main St, Safeway Pharmacy #1751, Molalla, OR 97038 Phone: 503-829-4855 Fax: 503-829-4780 |
Lehua Chen Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1525 W Main St, Molalla, OR 97038 Phone: 503-829-4855 |
News Archive
La Jolla Institute scientist wins Malpighi Medal for pioneering work in heart disease
Klaus Ley, M.D, a scientist at the La Jolla Institute for Allergy & Immunology, was recently awarded the prestigious Malpighi Medal at the World Congress for Microcirculation in Paris, France. A lifetime achievement award presented by the European Society for Microcirculation, Dr. Ley received the honor in recognition of his pioneering endeavors in vascular immunology, a scientific discipline that he helped to pioneer, which looks at novel immune-based approaches to combating heart disease. He is only the 17th recipient of the biennial award worldwide.
Propranolol drug can improve language abilities, social functioning of people with ASD
People with an Autism Spectrum Disorder (ASD) often have trouble communicating and interacting with others because they process language, facial expressions and social cues differently.
Tailored anti-clotting medications reduce adverse effects after percutaneous coronary intervention
Individually tailored anti-clotting medication dosing significantly cut the rate of adverse events after non-emergent percutaneous coronary intervention (PCI) with stenting, researchers reported at the American Heart Association's Scientific Sessions 2008. Results of the Tailored Clopidogrel Loading Dose According to Platelet Reactivity Monitoring to Prevent Stent Thrombosis study were presented as a late-breaking clinical trial.
AXA PPP healthcare introduces new Facebook app for cancer patients
AXA PPP healthcare has launched a new Facebook application - little big things - for people affected by cancer to share inspirational tips and practical information on coping with the disease and its treatment.
CytoDyn receives FDA approval to start Phase 2b study of PRO 140 for treatment of HIV-1
CytoDyn Inc., a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, announced today the Company has received approval from the United States Food and Drug Administration (FDA) to commence patient screening of a Phase 2b study of PRO 140, a monoclonal CCR5 antibody, for the treatment of patients with Human Immunodeficiency Virus Type 1.
› Verified 2 days ago